1
Beije, Nick, Kraan, Jaco, Taal, Walter, van der Holt, Ronnie, Oosterkamp, HM, Walenkamp, AM, Beerepoot, L, Hanse, M, van Linde, ME, Otten, A, Vernhout, René, de Vos, FYF, Gratama, Jan willem, Sleijfer, Stefan, van den Bent, Martin
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , R , Oosterkamp , HM , Walenkamp , AM , Beerepoot , L , Hanse , M , van Linde , ME , Otten , A , Vernhout , R , de Vos , FYF , Gratama , J W , Sleijfer , S & van den Bent , M 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Journal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , R , Oosterkamp , HM , Walenkamp , AM , Beerepoot , L , Hanse , M , van Linde , ME , Otten , A , Vernhout , R , de Vos , FYF , Gratama , J W , Sleijfer , S & van den Bent , M 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Journal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
2
Franken, Margreet, Kanters, Tim, Coenen, JL, De Jong, P, Koene, HR, Lugtenburg, Elly, Jager, Agnes, Uyl - de Groot, Carin
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018
Veröffentlicht in: Franken , M , Kanters , T , Coenen , JL , De Jong , P , Koene , HR , Lugtenburg , E , Jager , A & Uyl - de Groot , C 2018 , ' Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands ' , Anti-Cancer Drugs , vol. 29 , no. 8 , pp. 791-801 . https://doi.org/10.1097/CAD.0000000000000648;
2018